Advanced Biomed announces 1-for-20 reverse stock split to regain Nasdaq compliance

Advanced Biomed Inc.

Reverse split effective Feb 20, 2026; every 20 shares become 1 share, par value unchanged $0.001.
Outstanding shares reduced from 27,290,710 to approx 1,364,536; authorized shares unchanged.
New CUSIP 00752P203; stock continues trading under symbol ADVB; no fractional shares issued.
Split aims to meet Nasdaq minimum bid price of $1.00 per share.
Stockholder approval obtained via written consent on Jan 12, 2026; board set ratio Jan 30.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Advanced Biomed Inc.: Amended certificate of incorporation to effect a 1-for-20 reverse stock split, effective February 20, 2026, with no change to authorized shares or par value (effective 2026-02-20).

Change: charter amendment
Effective: 2026-02-20

Exact text from the filing

On February 3, 2026, Advanced Biomed Inc. (the “Company”) filed with the Secretary of State of the State of Nevada an amendment (the “Certificate of Amendment”) to its amended and restated certificate of incorporation, as amended (the “Certificate of Incorporation”), to effect a reverse stock split of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a ratio of 1-for-20 (the “Reverse Stock Split”).

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Advanced Biomed Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-020807

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.